Form 4 Filing for Arcutis Biotherapeutics, Inc.

This filing details transactions by Howard G. Welgus, a director at Arcutis Biotherapeutics, Inc. On June 5, 2026, Welgus acquired 5,778 shares of Common Stock and was granted an option to buy 16,667 shares of Common Stock. The RSUs acquired are subject to vesting conditions tied to continued service, with full vesting occurring on the earlier of the first anniversary of the grant date or immediately before the next annual meeting. The stock option also vests and becomes exercisable under similar conditions. The reported transactions are marked as direct ownership.